Gainers
- TC BioPharm (Holdings) TCBP stock rose 71.6% to $1.09 during Thursday's pre-market session. The market value of their outstanding shares is at $30.5 million.
- Reshape Lifesciences RSLS stock rose 15.49% to $0.82. The company's market cap stands at $2.8 million. As per the news, the Q1 earnings report came out 3 days ago.
- Monopar Therapeutics MNPR shares moved upwards by 14.81% to $2.48. The company's market cap stands at $31.2 million.
- Liquidia LQDA shares moved upwards by 9.04% to $3.98. The market value of their outstanding shares is at $256.0 million.
- Evelo Biosciences EVLO shares increased by 8.88% to $1.96. The company's market cap stands at $105.1 million.
- Concert Pharma CNCE stock increased by 8.11% to $5.06. The company's market cap stands at $183.8 million.
Losers
- NRX Pharmaceuticals NRXP shares decreased by 39.9% to $0.83 during Thursday's pre-market session. The market value of their outstanding shares is at $55.3 million.
- Avadel Pharmaceuticals AVDL shares decreased by 23.08% to $2.6. The market value of their outstanding shares is at $153.4 million.
- Genocea Biosciences GNCA stock decreased by 8.7% to $0.08. The company's market cap stands at $4.9 million.
- Motus GI Hldgs MOTS shares declined by 8.34% to $0.28. The company's market cap stands at $15.1 million.
- Verrica Pharmaceuticals VRCA stock declined by 7.97% to $1.85. The company's market cap stands at $50.9 million.
- Bluejay Diagnostics BJDX shares decreased by 7.41% to $1.0. The company's market cap stands at $20.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BJDXBluejay Diagnostics Inc
$3.85-13.3%
EVLOEvelo Biosciences Inc
$0.00050-99.8%
LQDALiquidia Corp
$13.90-3.20%
MNPRMonopar Therapeutics Inc
$40.60-2.07%
MOTSMotus GI Holdings Inc
$0.00010-%
NRXPNRX Pharmaceuticals Inc
$2.81-12.7%
RSLSReshape Lifesciences Inc
$4.35-2.03%
TCBPTC BioPharm (Holdings) PLC
$0.33914.67%
VRCAVerrica Pharmaceuticals Inc
$0.7100-1.77%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in